Low serum vitamin D levels are not associated with increased postoperative pain and opioid requirements: a historical cohort study Des taux faibles de vitamine D sérique ne sont pas associés à une augmentation de la douleur postopératoire et des besoins en opioïdes: une étude de cohorte historique -1 and B 20 ngÁmL -1 in either TWA pain score (P = 0.91) or total opioid consumption (P = 0.18). Conclusion We did not find any association between preoperative vitamin D levels and postoperative pain scores/opioid consumption in morbidly obese patients undergoing bariatric surgery.
three months of their surgery were included in the analysis. We assessed the relationship between vitamin D levels and the time-weighted average (TWA) of pain scores and total opioid consumption using multivariable regression models adjusted for potential confounders. As a secondary analysis, we compared the TWA of pain scores and opioid consumption between patients who were vitamin D deficient (B 20 ngÁmL -1 ) and those who were not (vitamin D [ 20 ngÁmL -1 ). Results The mean (SD) TWA pain score was 3.8 (1.5) and the median interquartile range [IQR] total opioid consumption (morphine equivalent) was 15.6 [18.2] mg during the first 72 hr postoperatively. The median [IQR] vitamin D concentration was 21.8 [17.1] ngÁmL -1 . The vitamin D level was not significantly associated with either the TWA pain score (Pearson correlation: -0.003; 97.5% confidence interval [CI] : -0.17 to 0.16) or opioid consumption (Spearman correlation: -0.13; 97.5% CI: -0.30 to 0.03). After adjusting for confounders, the estimated average change in TWA pain score was 0.01 (97.5% CI: -0.08 to 0.11) for a five-unit increase in vitamin D (P = 0.77). The estimated ratio of geometric means of total opioid consumption was 0.94 (97.5% CI: 0.86 to 1.03) for a five-unit increase in vitamin D concentration (P = 0.12). No difference was found between patients with vitamin D concentrations [ 20 ngÁmL -1 and B 20 ngÁmL -1 in either TWA pain score (P = 0.91) or total opioid consumption (P = 0.18). Conclusion We did not find any association between preoperative vitamin D levels and postoperative pain scores/opioid consumption in morbidly obese patients undergoing bariatric surgery.
Résumé
Objectif Un déficit en vitamine D a été associé à des syndromes chroniques de douleurs non spécifiques de l'appareil locomoteur; nous manquons toutefois d'études pour ce qui concerne ses rapports avec la douleur postopératoire. Nous avons testé l'hypothèse que des taux plus faibles de vitamine D préopératoire étaient associés à une augmentation de la douleur postopératoire et/ou Vitamin D deficiency is a common public health problem. In the United States alone, about 25 million people are deficient in vitamin D. 1 On a global scale, this translates into nearly 100 million people worldwide who have vitamin D deficiency or insufficiency. 2 The prevalence of vitamin D deficiency in morbidly obese patients presenting for bariatric surgery is estimated to be as high as 60%. 3 This has been attributed to an increase in sequestration of vitamin D in adipose tissues, 4 secondary hyperparathyroidism, 5 and avoidance of sunlight with a tendency towards wearing protective clothing. 6 Additionally, this deficiency state is exacerbated after bariatric surgery. [7] [8] [9] Vitamin D has been linked with important anti-inflammatory and immunomodulatory roles where it regulates cytokines and profibrotic and pro-inflammatory pathways that play an important role in pain perception and propagation. [10] [11] [12] [13] [14] [15] Clinically, vitamin D deficiency has been associated with chronic non-specific musculoskeletal pain syndromes and migraines. [16] [17] [18] Vitamin D deficient individuals have reported pain even in the absence of actual bone pathology. 19 A Cochrane review highlighted an association between pain, geographic latitude and sun exposure, which may be an indirect pointer to the role of hypovitaminosis D and its role in pain. 20 In patients with advanced malignancies, vitamin D deficiency has been related to pain, fatigue, and muscle weakness. 21 Furthermore, replacement therapy has been reported to improve bone pain and muscle strength in patients with prostate cancer. 21, 22 A recent case series reported treatment with vitamin D in the palliative medicine clinic where patients with chronic cancer pain refractory to conventional therapy showed a favourable response. System and paper charts were used to recover patient information, including age, sex, race, and body mass index, smoking status, and comorbidities (e.g., diabetes mellitus, chronic pain disorder, and chronic use of steroids and/or opioids). The analysis also included the available pain scores (11-point numerical rating scale: 0-10; 0 = ''no pain at all'' and 10 = ''worst pain imaginable'') collected in the postanesthesia care unit (PACU) (every 15 min) and surgical wards (every four hours), according to standard practice, as well as the doses of analgesic medications the patients received in these settings during the first 72 hr after surgery.
All patients who had a 25-hydroxyvitamin D measurement within three months from the date of surgery were considered for inclusion. Since the prevalence of vitamin D deficiency is significant in this cohort, the decision to order vitamin D levels was left to the discretion of the clinicians who assessed the patients initially. We also used techniques to quantify potential selection bias arising out of clinician discretion (detailed in statistical section). A single vitamin D concentration value was used for the analysis, and if multiple measurements were obtained within the above time frame, the value measured closest to the date of surgery was used. Vitamin D concentrations were obtained from the hospital Laboratory Medicine registry. We excluded patients with missing outcomes and/or covariables.
Postoperative pain management
According to standard practice in the Cleveland Clinic, patients are evaluated by the nursing staff upon their arrival in the PACU, and if required, analgesic medications are administered according to anesthesiologists' orders. Current standard opioids administered for postoperative pain management in the PACU are fentanyl, morphine, and/or hydromorphone. Patients are given incremental doses of the prescribed opioids to keep pain scores (numerical rating scale) below 4, and vital signs are monitored: electrocardiography, heart rate, noninvasive blood pressure, and pulse oximetry. In the postoperative ward, patients receive intravenous opioids by either patientcontrolled analgesia or incremental doses of opioids until they can tolerate oral medications, per the standards of the surgical team. Data were collected from medical records, and the total amount of opioids used in 72 hr was converted to a morphine equivalent for analysis (Table 1) .
Statistical analysis
Patient characteristics and outcomes were summarized using the standard summary statistics, as appropriate. To investigate the potential selection bias, we compared patients included in the study with those excluded using the absolute standardized difference (ASD), that is, the absolute difference in means or proportions divided by the pooled standard deviation. Values of 0.2, 0.5, and 0.8 represent small, medium, and large differences, respectively. 24 We assessed the relationships between vitamin D concentration and the time-weighted average (TWA) of pain scores and total opioid consumption in the first 72 hr after surgery after logarithmic transformation -we used log 2 (x ? 1) transformation due to the existence of zeros. We reported the Pearson and Spearman correlation coefficients, as appropriate, and assessed the relationships using a multivariable regression model, adjusting for potential confounders. The TWA of pain scores is equal to the sum of the portion of each time interval in-between two adjacent pain score measurements multiplied by the average of the corresponding two pain scores divided by the time interval between the first and the last pain score measurements. We adjusted for pre-specified potential confounders, including age, sex, body mass index, smoking status, diabetes mellitus, chronic pain syndrome, and chronic usage of steroids and opioids. Nonetheless, chronic pain syndrome and chronic usage of opioids may be potential mediators between vitamin D deficiency and postoperative pain. Adjusting for mediators would ''wash out'' the associations of interest. Thus, we conducted a sensitivity analysis where we removed these two covariates from the multivariable model.
In addition, we used the same methods as above to conduct a pre-specified secondary analysis comparing . A Bonferroni correction was used to adjust for multiple testing; the significance criterion for each outcome was P \ 0.025 (i.e., 0.05/2). SAS Ò software version 9.3 (SAS Institute, Cary, NC, USA) was used for all analyses.
Results
During July 2005-December 2009, 476 adult patients underwent laparoscopic bariatric surgery at the Cleveland Clinic Main Campus, and 210 patients had a 25-hydroxyvitamin D measurement within three months from the date of surgery. After exclusion for incomplete data, 185 patients were included in the analysis (Table 1) . There was a slight imbalance (i.e., ASD [ 0.2) between patients who were included in our study and those who were excluded, specifically in terms of demographics, baseline characteristics, and outcomes. For example, patients who were included in the analysis were more likely to be Caucasian (vs African American), to have a lower body mass index and a lower TWA pain score, and to receive more opioids in general; they were also less likely to have chronic pain syndrome ( Table 2) .
We observed that the mean (SD) of the TWA of pain score was 3.8 (1.5) (Fig. 1) . Vitamin D was not significantly associated with either the TWA of pain score (Pearson correlation: -0.003; 97.5% CI: -0.17 to 0.16; P = 0.97) or total opioid consumption (Spearman correlation: -0.13; 97.5% CI: -0.30 to 0.03; P = 0.07) (Fig. 2) . After adjusting for potential confounders, the estimated average change in the TWA of pain score was 0.01 (97.5% CI: -0.08 to 0.11) for a five-unit increase in vitamin D concentration (P = 0.77). The estimated ratio of geometric means of total opioid consumption was 0.94 (97.5% CI: 0.86 to 1.03) for a five-unit increase in vitamin D concentration (P = 0.12). The sensitivity analysis provided consistent results: the average change in pain score was 0.03 (97.5% CI: -0.07 to 0.13; P = 0.55), and the ratio of geometric means of opioid consumption was 0.94 (97.5% CI: 0.86 to 1.03; P = 0.13).
Similarly, no difference was found between patients with vitamin D concentration [ 20 ngÁmL -1 vs B 20 ngÁmL -1 , TWA of pain score [mean (SD): 3.7 (1.5) vs 3.9 (1.5), respectively], or total opioid consumption (median 
Discussion
This is a novel study to look at the association between vitamin D and postoperative pain and opioid consumption.
In this study population, we found that vitamin D levels
were not associated with pain scores or with opioid consumption in the first 72 hr following surgery. This result is surprising since previous studies have shown that vitamin D deficiency can be associated with the development of chronic nonspecific musculoskeletal pain syndrome, 25 myalgia, 17 chronic low back pain, 26 and chronic tension-type headache. 27 Some studies even show that supplementation contributes to improvements in pain. 28, 29 Decreased serum vitamin D levels were also associated with diabetic peripheral neuropathy, which is an important reason for chronic pain. 30 A number of mechanisms have been proposed to explain the role of vitamin D deficiency in chronic pain syndromes. The most important mechanism related to pain is the Fig. 1 Boxplots of time-weighted average verbal response pain scores, opioid consumption in mg (intravenous morphine equivalent dose), and vitamin D concentration for 185 patients included in the analysis. The first quartile, median, and third quartile comprise the boxes; whiskers extend to the most extreme observations within 1.5 times the interquartile range of the first and third quartiles, respectively; points outsides these whiskers are displayed individually with either the TWA of pain score (P = 0.77) or the total opioid consumption (P = 0.12), after adjusting for potential confounders immune-modulatory action of vitamin D shown in in vitro and in vivo studies. Recent studies suggest that vitamin D has anti-inflammatory actions via suppression of the expression of COX-2 (an enzyme involved in the synthesis of prostaglandins) and upregulation of the expression of the enzyme that inactivates prostaglandins. 31 In addition to proposed immunomodulatory mechanisms, vitamin D receptors and vitamin D metabolizing enzymes have been found in unmyelinated calcitonin gene-related peptide-positive neurons in the dorsal root ganglia of rats, which suggests that 1,25(OH) 2 D3 (which is a product of 25-hydroxy vitamin D) might affect those sensory neurons via nuclear or extranuclear signalling pathways. 32 Tague et al. have shown that laboratory rats on a two-to four-week vitamin D deficient diet showed skeletal muscle hypersensitivity. The rats' sensory neurons showed enriched vitamin D receptor expression, suggesting that the deficiency state triggers hyperinnervation of skeletal muscle nociceptors and thereby contributes to skeletal muscle pain. 33 Significant amounts of vitamin D receptors have been revealed in the ventromedial hypothalamus of the human brain, which sends projections to the periaqueductal grey matter and thereby potentially regulates nociceptive signalling through the spinal cord via descending projections of the dorsal horns. 34 Although a biologic explanation for the role of vitamin D in states of chronic pain seems plausible, this view was not supported in a recent meta-analysis. 35 Straube et al. 35 conducted a meta-analysis of 22 relevant studies in which they reported vitamin D levels and investigated the effects of vitamin D treatment on chronic pain conditions. They could not find convincing evidence of lower vitamin D levels in chronic pain conditions vs control populations or any significant correlation between improvement in pain and vitamin D supplementation. Our findings are in agreement with Straube et al. 35 Our study has a few limitations in addition to the ones inherent in retrospective chart reviews. For example, the median vitamin D level was higher than the accepted cut-off for vitamin D deficiency (\ 20 ngÁmL -1 ). In addition, these patients were non-consecutively enrolled over a period of five years (2005) (2006) (2007) (2008) (2009) , and the postoperative pain management regimen was not standardized. The type of surgery we assessed was less painful than open surgical procedures, which may have made the differences in outcome less obvious. Furthermore, any retrospective analysis, including ours, potentially suffers from selection bias. In other words, in the minority (39%, 185/476) of bariatric surgery patients included in the study, the nature of the relationship between vitamin D and pain scores as well as opioid consumption may not be representative of the relationship within the larger cohort of patients. The extent to which selection bias contributes to our conclusions remains unknown. Nevertheless, the bias is probably not substantial based on the evidence of small ASD values across demographics, baseline characteristics, and the outcomes of patients who were included vs those who were not. The largest ASD value of 0.35 indicates only a small difference. A prospective study could potentially address these limitations by using: a larger sample size, consecutive enrolment, and stratification of vitamin D levels according to race, approximate geographical latitude, season of collection, and type of procedure.
In conclusion, we did not find any association between vitamin D levels, postoperative pain scores and opioid consumption in patients presenting for bariatric surgery. Additional well-designed randomized controlled trials are needed to determine the effect of vitamin D on postoperative pain scores and opioid consumption.
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